Local Institution - 1006-Ph2

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Lung cancer

Closed trials

• Recruiting

  Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

  NCT04613596· Phase 2/3· Mirati Therapeutics Inc.· Source